News

WebMD… the next takeover target? (Morning Read)

WedbMD’s consumer portal ranks as the top health site on the Web, and the company’s financials are very healthy. It could be an attractive target for any offline media company that wanted to make a splash in an online category that performed well even during the midst of the recession, suggests paidContent.org.

Highlights of the important and interesting in the world of healthcare:

Could WebMD  be next? WedbMD’s consumer portal ranks as the top health site on the Web, and the company’s financials are very healthy. It could be an attractive target for any offline media company that wanted to make a splash in an online category that performed well even during the midst of the recession, suggests paidContent.org.

Nestle to solve diseases with food. Nestle, the world’s biggest foods group, has unveiled a new subsidiary bridging its core business and pharmaceuticals that will target nutritional solutions to diseases such as diabetes, obesity, heart problems and Alzheimer’s, according to the Financial Times.

Preventive health, brought to you by the CDC. The Department of Health and Human Services is making $100 million in grants — mostly through the Centers for Disease Control and Prevention — to fund preventive health programs like tobacco quit lines and HIV testing programs in states and local communities.

How health reform could affect you. The Robert Wood Johnson Foundation has put together a series of briefs that explain how health reform could affect young adults to hospitals and physicians, compliments of the Healthcare Economist blog.

Angelgate, The Sequel. The brouhaha that erupted after TechCrunch founder Michael Arrington uncovered a meeting of top angel investors in a San Francisco restaurant just won’t go away, notes the Wall Street Journal’s Venture Capital Dispatch blog.

Cook Medical aims stent at renal artery disease. Cook Medical in Bloomington, Indiana, has submitted its Pre-Market Approval application to the Food and Drug Administration for its new balloon-expandable stent for renal artery disease.

Topics